Bristol Myers (BMY) Squibb is expanding its existing strategic productivity initiative to include approximately $2B in additional annualized cost savings by the end of 2027. Under this expanded ...
Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback